… range of rheumatic and musculoskeletal diseases (RMDs). Compelling evidence suggests
that the measurement of IFN-I pathway activation may have clinical value. Although several …

… indicators (QIs) and improved patient outcomes. Therefore, we examined the associations
… clinical outcomes among patients with rheumatic and musculoskeletal diseases (RMDs). …

… Our findings emphasize the need to develop common strategies among all chronic disease
to improve work outcome in daily clinical care. Professionals in rheumatological care could …

… The clinical outcomes were generally favorable with some residual disability. The mortality
rate in this study was quite low, mostly due to nosocomial infections with multi-organ failure. …

… and clinical outcome in CKD patients is still unclear. That is why we conducted a prospective
cohort study to evaluate the association between chronic MS pain and clinical outcome in …

… In multivariate analyses controlling for clinical and demographic factors among patients …
clinical outcomes than non-referral (p = 0.02). Referral was not associated with clinical outcomes …

… clinical outcomes of services provided. The purposes of this study were: (1) to describe the
baseline characteristics, clinical outcomes, … physical therapy for musculoskeletal conditions in …

… disease spectra are associated with gradients of physical … disease spectrum which consisted
of hypertension, ischaemic heart disease and heart failure, and a musculoskeletal disease …

… activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in
patients with rheumatic musculoskeletal diseases. Ann Rheum Dis 2020. doi:doi:10.1136/…

… Background: To determine the clinical outcomes in patients with … outcome was continuously
disease free in 12 cases, no evidence of disease in 3, alive with disease in 3, died of disease …